This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Portola Pharmaceuticals, Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Michael McNevin: Innovator in Pharmaceutical Chemistry
Introduction
Michael McNevin is a notable inventor based in Summit, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds.
Latest Patents
Michael McNevin holds 1 patent for his work on crystalline forms of a factor Xa inhibitor. His patent, titled "Crystalline forms of a maleate salt of betrixaban," provides compositions and methods of preparation or use thereof. This invention is crucial in the ongoing efforts to develop effective anticoagulant therapies.
Career Highlights
Michael is currently employed at Portola Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical innovations. His work has been instrumental in the development of new therapeutic agents that can improve patient outcomes.
Collaborations
Throughout his career, Michael has collaborated with talented professionals, including Vincent R Capodanno and Liam Corcoran. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Michael McNevin's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in medicine. His work continues to influence the development of new treatments that can benefit patients worldwide.